← Back to patent-cliff list
Metformin Hydrochloride/Sitagliptin Hydrochloride
Tier C — Watch / tradeMetformin Hydrochloride/Sitagliptin Hydrochloride
Sandoz Bv
Originator
2019
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：PRKAB1, DPP4
Regional status
US
-
EU
Approved
2019-12-10
China
-
Japan
-
Factories producing this API10
Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.
10 producing factories on file — sign in to view the named list (factory details are not shown to guests).
Sign in to view factories →Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
When does the Metformin Hydrochloride/Sitagliptin Hydrochloride patent expire?
No public expiry year is available for Metformin Hydrochloride/Sitagliptin Hydrochloride yet; this page updates once verified.
How do I get a quote for Metformin Hydrochloride/Sitagliptin Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-22